Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Disc Medicine, Inc. (IRON) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Disc Medicine, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1816736.
Total stock buying since 2020: $34,748,785.
Total stock sales since 2020: $312,376,576.
Total stock option exercises since 2020: $2,129,627.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 909,544 | $50,173,927 | 92,301 | $843,042 |
| 2024 | 388,891 | $14,000,076 | 402,404 | $26,728,372 | 75,617 | $706,299 |
| 2023 | 652,175 | $15,000,025 | 4,404,849 | $235,427,252 | 67,641 | $580,286 |
| 2022 | 955,000 | $1,333,684 | 22,500 | $47,025 | 0 | $0 |
| 2020 | 441,500 | $4,415,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 34,856 | $2,129,935 | 0 | $0 |
| 2025-07 | 0 | $0 | 96,057 | $5,635,493 | 40,000 | $394,400 |
| 2025-06 | 0 | $0 | 4,996 | $254,318 | 32,070 | $316,210 |
| 2025-05 | 0 | $0 | 8,777 | $439,497 | 0 | $0 |
| 2025-04 | 0 | $0 | 0 | $0 | 7,000 | $7,070 |
| 2025-03 | 0 | $0 | 741,102 | $40,409,678 | 0 | $0 |
| 2025-02 | 0 | $0 | 23,756 | $1,305,006 | 13,231 | $125,362 |
| 2024-12 | 0 | $0 | 14,748 | $969,693 | 14,748 | $25,159 |
| 2024-11 | 0 | $0 | 30,678 | $1,912,066 | 30,678 | $583,978 |
| 2024-10 | 0 | $0 | 201 | $10,226 | 201 | $1,981 |
| 2024-09 | 0 | $0 | 4,957 | $246,583 | 1,957 | $12,241 |
| 2024-08 | 0 | $0 | 201 | $8,762 | 201 | $1,981 |
| 2024-07 | 0 | $0 | 201 | $9,208 | 3,201 | $5,011 |
| 2024-06 | 388,891 | $14,000,076 | 0 | $0 | 0 | $0 |
| 2024-05 | 0 | $0 | 201 | $5,791 | 201 | $1,981 |
| 2024-04 | 0 | $0 | 2,560 | $81,879 | 24,430 | $73,967 |
| 2024-03 | 0 | $0 | 26,157 | $1,922,539 | 0 | $0 |
| 2024-01 | 0 | $0 | 322,500 | $21,561,625 | 0 | $0 |
| 2023-12 | 0 | $0 | 2,309,427 | $133,230,066 | 43,740 | $459,062 |
| 2023-11 | 0 | $0 | 5,000 | $253,871 | 5,000 | $73,450 |
| 2023-09 | 0 | $0 | 358,449 | $19,044,717 | 3,500 | $27,300 |
| 2023-08 | 0 | $0 | 452,393 | $23,832,652 | 7,521 | $12,516 |
| 2023-06 | 0 | $0 | 1,279,580 | $59,065,946 | 7,880 | $7,958 |
| 2023-02 | 652,175 | $15,000,025 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-22 | Bitterman Kevin | Sale | 2,287 | 61.03 | 139,575 |
| 2025-08-14 | Bitterman Kevin | Sale | 7,212 | 60.99 | 439,859 |
| 2025-08-13 | Bitterman Kevin | Sale | 24,962 | 61.15 | 1,526,426 |
| 2025-08-05 | Bitterman Kevin | Sale | 395 | 60.95 | 24,075 |
| 2025-07-30 | Bitterman Kevin | Sale | 8,492 | 61.04 | 518,351 |
| 2025-07-24 | Bitterman Kevin | Sale | 13,033 | 61.17 | 797,228 |
| 2025-07-23 | Bitterman Kevin | Sale | 29,837 | 60.97 | 1,819,161 |
| 2025-07-18 | Bitterman Kevin | Sale | 664 | 61.13 | 40,590 |
| 2025-07-17 | Franchi Jean M. (Chief Financial Officer) | Sale | 2,031 | 59.00 | 119,829 |
| 2025-07-10 | Franchi Jean M. (Chief Financial Officer) | Sale | 2,000 | 57.50 | 115,000 |
| 2025-07-09 | Quisel John D (Chief Executive Officer) | Sale | 34,800 | 55.72 | 1,938,882 |
| 2025-07-09 | Quisel John D (Chief Executive Officer) | Option Ex | 34,800 | 9.86 | 343,128 |
| 2025-07-03 | Quisel John D (Chief Executive Officer) | Sale | 5,200 | 55.09 | 286,452 |
| 2025-07-03 | Quisel John D (Chief Executive Officer) | Option Ex | 5,200 | 9.86 | 51,272 |
| 2025-06-27 | Savage William Jacob (Chief Medical Officer) | Option Ex | 32,070 | 9.86 | 316,210 |
| 2025-06-16 | Franchi Jean M. (Chief Financial Officer) | Sale | 2,000 | 52.26 | 104,518 |
| 2025-06-06 | Savage William Jacob (Chief Medical Officer) | Sale | 2,996 | 50.00 | 149,800 |
| 2025-05-20 | Savage William Jacob (Chief Medical Officer) | Sale | 6,677 | 50.04 | 334,130 |
| 2025-05-02 | Savage William Jacob (Chief Medical Officer) | Sale | 2,100 | 50.17 | 105,367 |
| 2025-04-07 | Quisel John D (Chief Executive Officer) | Option Ex | 7,000 | 1.01 | 7,070 |
| 2025-03-24 | Orbimed Genesis Gp Llc | Sale | 5,738 | 54.11 | 310,483 |
| 2025-03-24 | Ashiya Mona | Sale | 5,738 | 54.11 | 310,483 |
| 2025-03-21 | Orbimed Genesis Gp Llc | Sale | 10,011 | 54.00 | 540,594 |
| 2025-03-21 | Ashiya Mona | Sale | 10,011 | 54.00 | 540,594 |
| 2025-03-20 | Orbimed Genesis Gp Llc | Sale | 2,762 | 54.01 | 149,175 |
| 2025-03-20 | Ashiya Mona | Sale | 2,762 | 54.01 | 149,175 |
| 2025-03-19 | Orbimed Genesis Gp Llc | Sale | 39,656 | 54.02 | 2,142,217 |
| 2025-03-19 | Ashiya Mona | Sale | 39,656 | 54.02 | 2,142,217 |
| 2025-03-12 | Orbimed Genesis Gp Llc | Sale | 83,182 | 54.74 | 4,553,798 |
| 2025-03-12 | Ashiya Mona | Sale | 83,182 | 54.74 | 4,553,798 |
| 2025-03-11 | Orbimed Genesis Gp Llc | Sale | 27,056 | 54.01 | 1,461,294 |
| 2025-03-11 | Ashiya Mona | Sale | 27,056 | 54.01 | 1,461,294 |
| 2025-03-10 | Orbimed Genesis Gp Llc | Sale | 202,146 | 54.65 | 11,047,278 |
| 2025-03-10 | Ashiya Mona | Sale | 202,146 | 54.65 | 11,047,278 |
| 2025-02-18 | Savage William Jacob (Chief Medical Officer) | Sale | 1,638 | 54.58 | 89,402 |
| 2025-02-18 | Khara Rahul (Chief Legal Officer) | Sale | 1,161 | 54.58 | 63,367 |
| 2025-02-18 | Yu Jonathan Yen-wen (Chief Operating Officer) | Sale | 1,610 | 54.58 | 87,873 |
| 2025-02-18 | Stephenson Pamela (Chief Commercial Officer) | Sale | 3,137 | 54.58 | 171,217 |
| 2025-02-18 | Franchi Jean M. (Chief Financial Officer) | Sale | 3,136 | 54.58 | 171,162 |
| 2025-02-18 | Quisel John D (Chief Executive Officer) | Sale | 5,574 | 54.58 | 304,228 |
| 2025-02-03 | Savage William Jacob (Chief Medical Officer) | Option Ex | 5,731 | 2.65 | 15,187 |
| 2025-02-03 | Khara Rahul (Chief Legal Officer) | Sale | 7,500 | 55.70 | 417,757 |
| 2025-02-03 | Khara Rahul (Chief Legal Officer) | Option Ex | 7,500 | 14.69 | 110,175 |
| 2024-12-16 | Quisel John D (Chief Executive Officer) | Sale | 12,791 | 65.95 | 843,528 |
| 2024-12-16 | Quisel John D (Chief Executive Officer) | Option Ex | 12,791 | 1.01 | 12,918 |
| 2024-12-02 | White William Richard | Sale | 1,957 | 64.47 | 126,165 |
| 2024-12-02 | White William Richard | Option Ex | 1,957 | 6.25 | 12,241 |
| 2024-11-25 | Savage William Jacob (Chief Medical Officer) | Sale | 14,183 | 65.93 | 935,071 |
| 2024-11-25 | Savage William Jacob (Chief Medical Officer) | Option Ex | 14,183 | 11.68 | 165,657 |
| 2024-11-15 | Savage William Jacob (Chief Medical Officer) | Sale | 9,158 | 60.27 | 551,906 |
| 2024-11-15 | Savage William Jacob (Chief Medical Officer) | Option Ex | 9,158 | 9.86 | 90,297 |
| 2024-11-04 | White William Richard | Sale | 7,136 | 58.27 | 415,800 |
| 2024-11-04 | White William Richard | Option Ex | 7,136 | 45.69 | 326,043 |
| 2024-11-01 | White William Richard | Sale | 201 | 46.21 | 9,289 |
| 2024-11-01 | White William Richard | Option Ex | 201 | 9.86 | 1,981 |
| 2024-10-01 | White William Richard | Sale | 201 | 50.88 | 10,226 |
| 2024-10-01 | White William Richard | Option Ex | 201 | 9.86 | 1,981 |
| 2024-09-16 | Savage William Jacob (Chief Medical Officer) | Sale | 1,500 | 47.41 | 71,115 |
| 2024-09-03 | Savage William Jacob (Chief Medical Officer) | Sale | 1,500 | 50.59 | 75,885 |
| 2024-09-03 | White William Richard | Sale | 1,957 | 50.89 | 99,583 |
| 2024-09-03 | White William Richard | Option Ex | 1,957 | 6.25 | 12,241 |
| 2024-08-01 | White William Richard | Sale | 201 | 43.59 | 8,762 |
| 2024-08-01 | White William Richard | Option Ex | 201 | 9.86 | 1,981 |
| 2024-07-08 | Quisel John D (Chief Executive Officer) | Option Ex | 3,000 | 1.01 | 3,030 |
| 2024-07-01 | White William Richard | Sale | 201 | 45.81 | 9,208 |
| 2024-07-01 | White William Richard | Option Ex | 201 | 9.86 | 1,981 |
| 2024-06-17 | Orbimed Genesis Gp Llc | Buy | 83,334 | 36.00 | 3,000,024 |
| 2024-06-17 | Ashiya Mona | Buy | 83,334 | 36.00 | 3,000,024 |
| 2024-06-17 | Bitterman Kevin | Buy | 222,223 | 36.00 | 8,000,028 |
| 2024-05-01 | White William Richard | Sale | 201 | 28.82 | 5,791 |
| 2024-05-01 | White William Richard | Option Ex | 201 | 9.86 | 1,981 |
| 2024-04-11 | White William Richard | Sale | 2,560 | 31.98 | 81,879 |
| 2024-04-11 | White William Richard | Option Ex | 2,560 | 6.25 | 16,012 |
| 2024-04-10 | Savage William Jacob (Chief Medical Officer) | Option Ex | 21,870 | 2.65 | 57,955 |
| 2024-03-05 | Bitterman Kevin | Sale | 26,157 | 73.50 | 1,922,539 |
| 2024-01-23 | Atlas Venture Associates Opportunity Ii, Llc (10% Owner) | Sale | 150,000 | 67.65 | 10,147,500 |
| 2024-01-23 | Bitterman Kevin (Director) | Sale | 102,500 | 67.65 | 6,934,125 |
| 2024-01-10 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 50,000 | 64.00 | 3,200,000 |
| 2024-01-10 | Bitterman Kevin (Director) | Sale | 20,000 | 64.00 | 1,280,000 |
| 2023-12-27 | Bryce Joanne (Chief Financial Officer) | Option Ex | 3,000 | 9.86 | 29,580 |
| 2023-12-18 | Orbimed Genesis Gp Llc | Sale | 1,724 | 59.24 | 102,129 |
| 2023-12-18 | Orbimed Genesis Gp Llc | Option Ex | 1,724 | 38.00 | 65,512 |
| 2023-12-18 | Ashiya Mona | Sale | 1,724 | 59.24 | 102,129 |
| 2023-12-18 | Ashiya Mona | Option Ex | 1,724 | 38.00 | 65,512 |
| 2023-12-14 | Orbimed Genesis Gp Llc | Sale | 433,400 | 57.24 | 24,595,646 |
| 2023-12-14 | Ashiya Mona | Sale | 433,400 | 57.24 | 24,595,646 |
| 2023-12-14 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 51,374 | 59.01 | 3,031,322 |
| 2023-12-14 | Bitterman Kevin (Director) | Sale | 20,549 | 59.01 | 1,212,493 |
| 2023-12-13 | Orbimed Genesis Gp Llc | Sale | 106,700 | 58.56 | 6,248,352 |
| 2023-12-13 | Ashiya Mona | Sale | 106,700 | 58.56 | 6,248,352 |
| 2023-12-13 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 8,871 | 60.24 | 534,433 |
| 2023-12-13 | Bitterman Kevin (Director) | Sale | 3,548 | 60.24 | 213,749 |
| 2023-12-12 | Bryce Joanne (Chief Financial Officer) | Sale | 2,500 | 65.22 | 163,062 |
| 2023-12-12 | Bryce Joanne (Chief Financial Officer) | Option Ex | 2,500 | 2.65 | 6,625 |
| 2023-12-12 | Orbimed Genesis Gp Llc | Sale | 27,300 | 60.16 | 1,642,368 |
| 2023-12-12 | Ashiya Mona | Sale | 27,300 | 60.16 | 1,642,368 |
| 2023-12-12 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 129,918 | 62.98 | 8,181,715 |
| 2023-12-12 | White William Richard | Sale | 33,511 | 63.63 | 2,132,371 |
| 2023-12-12 | White William Richard | Option Ex | 33,511 | 8.67 | 290,540 |
| 2023-12-12 | Bitterman Kevin (Director) | Sale | 51,967 | 62.98 | 3,272,673 |
| 2023-12-05 | Bryce Joanne (Chief Financial Officer) | Sale | 2,541 | 56.30 | 143,058 |
| 2023-12-05 | Bryce Joanne (Chief Financial Officer) | Option Ex | 1,281 | 1.01 | 1,293 |
| 2023-11-14 | Khara Rahul (General Counsel) | Sale | 4,900 | 50.79 | 248,871 |
| 2023-11-14 | Khara Rahul (General Counsel) | Option Ex | 4,900 | 14.69 | 71,981 |
| 2023-11-03 | Khara Rahul (General Counsel) | Sale | 100 | 50.00 | 5,000 |
| 2023-11-03 | Khara Rahul (General Counsel) | Option Ex | 100 | 14.69 | 1,469 |
| 2023-09-16 | Atlas Venture Associates X, Llc (10% Owner) | Sale | 2,115 | 53.22 | 112,560 |
| 2023-09-15 | Atlas Venture Associates X, Llc (10% Owner) | Sale | 260,894 | 53.16 | 13,869,125 |
| 2023-09-14 | Atlas Venture Associates X, Llc (10% Owner) | Sale | 94,440 | 53.05 | 5,010,042 |
| 2023-09-11 | Bryce Joanne (Chief Financial Officer) | Option Ex | 2,500 | 9.86 | 24,650 |
| 2023-09-01 | Bryce Joanne (Chief Financial Officer) | Sale | 1,000 | 52.99 | 52,990 |
| 2023-09-01 | Bryce Joanne (Chief Financial Officer) | Option Ex | 1,000 | 2.65 | 2,650 |
| 2023-08-21 | Savage William Jacob (Chief Medical Officer) | Option Ex | 3,000 | 2.65 | 7,950 |
| 2023-08-15 | Savage William Jacob (Chief Medical Officer) | Sale | 7,672 | 53.16 | 407,881 |
| 2023-08-15 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 184,000 | 52.40 | 9,641,600 |
| 2023-08-15 | Bitterman Kevin (Director) | Sale | 72,931 | 52.40 | 3,821,584 |
| 2023-08-14 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 175,000 | 53.27 | 9,321,725 |
| 2023-08-09 | Savage William Jacob (Chief Medical Officer) | Sale | 8,269 | 50.01 | 413,532 |
| 2023-08-01 | Bryce Joanne (Chief Financial Officer) | Sale | 4,521 | 50.06 | 226,330 |
| 2023-08-01 | Bryce Joanne (Chief Financial Officer) | Option Ex | 4,521 | 1.01 | 4,566 |
| 2023-06-30 | Macdonald Brian Richard (Chief Innovation Officer) | Sale | 4,924 | 45.69 | 224,972 |
| 2023-06-29 | Macdonald Brian Richard (Chief Innovation Officer) | Sale | 5,100 | 45.90 | 234,110 |
| 2023-06-28 | Macdonald Brian Richard (Chief Innovation Officer) | Sale | 5,100 | 50.14 | 255,734 |
| 2023-06-28 | Savage William Jacob (Chief Medical Officer) | Sale | 4,384 | 49.97 | 219,086 |
| 2023-06-28 | Bryce Joanne (Chief Financial Officer) | Sale | 10,072 | 50.34 | 507,044 |
| 2023-06-28 | Bryce Joanne (Chief Financial Officer) | Option Ex | 7,880 | 1.01 | 7,958 |
| 2023-06-28 | Novo Holdings A/s (10% Owner) | Sale | 1,250,000 | 46.10 | 57,625,000 |
| 2023-02-15 | Orbimed Genesis Gp Llc | Buy | 108,696 | 23.00 | 2,500,008 |
| 2023-02-15 | Ashiya Mona | Buy | 108,696 | 23.00 | 2,500,008 |
| 2023-02-15 | Blavatnik Len (10% Owner) | Buy | 434,783 | 23.00 | 10,000,009 |
| 2022-10-26 | Leonard Braden Michael | Sale | 22,500 | 2.09 | 47,025 |
| 2022-04-13 | Leonard Braden Michael | Buy | 191,769 | 1.52 | 291,680 |
| 2022-04-12 | Leonard Braden Michael | Buy | 258,744 | 1.40 | 360,947 |
| 2022-04-11 | Leonard Braden Michael | Buy | 504,487 | 1.35 | 681,057 |
| 2020-08-14 | Tananbaum James B. (President & CEO) | Buy | 441,500 | 10.00 | 4,415,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of IRON listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Disc Medicine, Inc. (symbol IRON, CIK number 1816736) see the Securities and Exchange Commission (SEC) website.